| Website | f-a-b-inc.com |
| Category | BioTech |
| Phone | 650-823-7829 |
| Employees | |
| Founded | 2003 |
| Description | pharmaceutical company |
| TOTAL | $21M |
| FUNDING TOTAL | $21M |
| Series B, 12/07 SV Life Sciences Alta Partners | $21M |
Fundamental Applied Biology (FAB), Inc. is creating new products and opportunities in protein vaccines and therapeutics with its revolutionary platform that provides unprecedented speed and control over protein expression. FAB’s proprietary biosynthetic Cell-Free Protein Synthesis (Cell-Free) activates protein expression from combined transcription and translation reactions without the need for living cells. This key element allows cell-free technology to circumvent many significant limitations associated with the in vivo platforms. Cell-Free has been successfully used by FAB and its partners for the production of: Novel vaccine constructs Peptides prone to proteolysis Therapeutic proteins that are difficult to express in soluble form Therapeutic proteins that are prone to variants and difficult to purify.
